Rise of Clinical Trials in Colombia

Clinical Trials in: Mexico, Argentina, Colombia and Brazil.

Locally-Based, Full Service CRO

Contact us today to learn more.

+ 0
Sites Throughout LATAM
+ 200
Patients in our network
+ 0
Conducted Studies
0 %
Lost-to-Follow Up rate
As a leading CRO in LATAM, we specialize in supporting clinical trials throughout the region. Our extensive experience and broad network of clinical sites enable us to execute trials with speed and efficiency, ensuring high patient recruitment and retention rates.

Rise of Clinical Trials in Colombia

Rise of Clinical Trials in Colombia – Clinical Trials in Latin America

In recent years, Colombia has experienced a significant transformation in its healthcare landscape, marked by the growing prominence of clinical trials. As pharmaceutical companies, research institutions, and healthcare providers increasingly turn their attention to this South American nation, Colombia is emerging as a burgeoning hub for medical research and innovation.

In this article, we will delve into the reasons behind the rise of clinical trials in Colombia, the opportunities it presents, and the potential impact on the nation’s healthcare sector and economy.

The Growth of Clinical Trials in Colombia

Clinical trials in Colombia have a history dating back several decades. Still, it’s in recent years that the country has seen a remarkable surge in the number of trials conducted. Several key factors have contributed to this growth:

  1. Streamlined Regulatory Environment: Colombia has made substantial strides in aligning its clinical trial regulations with international standards. The National Food and Drug Surveillance Institute (INVIMA) has worked to simplify and expedite the approval process for clinical trials, reducing administrative barriers and wait times for researchers.
  2. Diverse and Accessible Patient Population: Colombia boasts a richly diverse population, spanning various ethnicities and socioeconomic backgrounds. This diversity is a valuable asset for clinical trials, as it allows for the study of treatment effectiveness across a broad spectrum of patients.
  3. Cost-Effective Research: Conducting clinical trials in Colombia often proves to be more cost-effective than in developed countries. Lower labor costs, affordable healthcare services, and a favorable exchange rate make it an attractive destination for pharmaceutical companies and sponsors.
  4. Growing Healthcare Infrastructure: Colombia has made substantial investments in expanding and improving its healthcare infrastructure. World-class hospitals and research centers have sprung up across major cities, providing essential support for clinical trials.
  5. Collaborative Research Ecosystem: The synergy between pharmaceutical companies, academic institutions, and governmental agencies has fostered a robust research ecosystem in Colombia. This collaborative environment facilitates the design and execution of high-quality clinical trials.

Economic Impact

The rise of clinical trials in Colombia has not only been a boon to the healthcare sector but has also had a notable impact on the country’s economy:

  1. Job Creation: Clinical trials require a skilled workforce, including clinical research coordinators, nurses, and data analysts. As the number of trials increases, job opportunities in healthcare and research fields expand, contributing to reduced unemployment rates.
  2. Investment Inflow: Pharmaceutical companies and sponsors invest significantly in clinical trials, injecting funds into Colombia’s economy. These investments can be allocated to infrastructure development and capacity building.
  3. Intellectual Property and Innovation: Clinical trials often involve cutting-edge treatments and technologies. As Colombia becomes a hub for these trials, it has the potential to foster innovation within the healthcare sector, leading to the development of new therapies and medical devices.
  4. Improved Healthcare Infrastructure: The infrastructure enhancements made to accommodate clinical trials benefit the general population by providing better access to healthcare facilities and services.

Rise of Clinical Trials in Colombia

Rise of Clinical Trials in Colombia

Rise of Clinical Trials in Colombia

Challenges and Ethical Considerations

While the ascent of clinical trials in Colombia presents numerous opportunities, it also brings forth important challenges and ethical considerations:

  1. Informed Consent: Ensuring that participants fully comprehend the risks and benefits of clinical trials is of utmost importance. Overcoming language barriers and addressing varying levels of health literacy can be complex tasks.
  2. Regulatory Oversight: While regulatory reforms have improved the clinical trial landscape, ongoing vigilance is necessary to prevent any potential ethical violations or exploitation of vulnerable populations.
  3. Transparency in Reporting: The transparency of trial results is essential to maintain trust in the clinical trial process. It is imperative that data be made available to the scientific community and the public.
  4. Equitable Access: The benefits of clinical trials should be accessible to all socioeconomic groups in Colombia. Efforts must be made to tackle healthcare disparities and ensure fair access to trials.


The emergence of clinical trials in Colombia is a testament to the nation’s growing significance in the global healthcare and pharmaceutical research arena. With a favorable regulatory environment, a diverse patient population, and a collaborative research ecosystem, Colombia is now an appealing destination for clinical trials.

This trend not only bolsters the country’s economy but also holds the potential to drive innovation and improve healthcare outcomes for its citizens. Nevertheless, ethical considerations and challenges must be addressed to ensure that clinical trials in Colombia are conducted responsibly and ethically, benefiting both the scientific community and the general population.

As Colombia continues to establish itself as a center for clinical research, it is poised to play an increasingly influential role in shaping the future of medicine and healthcare worldwide.

Rise of Clinical Trials in Colombia

Source: Pro Colombia

Welcome to Cohortias!

of Latin America

Simplify Your Clinical Trials with Our Expert Infrastructure in Latin America

Say goodbye to the complex, costly, and disorganized process of conducting clinical trials. Our infrastructure in Latin America streamlines the launch of studies and ensures adherence to international standards. Schedule a call with us today to discover the path to simplified clinical research in Latin America.

Rise of Clinical Trials in Colombia

Explore What We Are Doing Better

We define ourselves as a unique team, capable of blending our academic background with a global business mindset to bring the highest standard of quality and operational excellence into clinical research in Latin America.

Early Phase Trials

- First-in-Human Studies.
- Get to patients faster, no IND necessary.
- Valid data for FDA submission.

Rescue Studies

- Regain lost time and boost patient recruitment.
- We work alongside Global CROs to get studies back on track.
- More than 200 sites available.

Phase II & III Trials

- Full-Service Clinical Outsourcing.
- Proven infrastructure that can handle any trial.
- Local Regulatory Experts
- Wide network of sites and physicians.

Medical Devices

- A fast-track platform that will meet your timeline.
- We take care of everything, from shipping requirements all the way to data collection.
Rise of Clinical Trials in Colombia

Full Service CRO in LATAM

Outsourcing Clinical Trials to Latin America

Unlock the advantages and opportunities of outsourcing clinical trials to Latin America. Diverse patient population, streamlined regulations, and cost-effectiveness

Lower Operating Costs

From lower labor costs to lower costs for rent, utilities, and equipment, you can save money on your clinical trial budget while still ensuring the quality of your trial

Access to Emerging Markets

Latin America offers access to emerging markets, providing an opportunity for pharmaceutical companies to expand their reach and reach new patient populations.

Rise of Clinical Trials in Colombia

Cohortias is redefining Clinical Research in Latin America

We are committed to become leaders in providing clinical research services in Latin America. Here at Cohortias, we combine our academic roots, proven experience and a large pool of patients from an extensive network of sites.

Our main purpose is to deliver high quality data.

Rise of Clinical Trials in Colombia

Clinical Research in Latin America

Cohortias has built an extensive and highly reputable network of clinical sites which can access patients in a timely manner and operate within a standard-of-care comparable to the U.S. healthcare system.


  • Site Management

  • Data Management

  • Site Selection

  • Regulatory Submissions

  • Clinical Monitoring

  • Protocol Development


Beta Trials Platform

  • First-in-human studies

Medical Devices

  • Pilot and Pivotal Device Studies

Phases I – III

  • We partner with our clients to bring their products in a fast and efficient manner to the market with the highest quality standards


  • Diabetes/Metabolic Syndromes
  • Infectious Diseases
  • Cardiovascular
  • Neurology
  • Respiratory
  • Oncology

Rise of Clinical Trials in Colombia

Clinical Research in Latin America

Academic Leadership and Extensive Clinical Site Network for Efficient Clinical Trials

  • Our peer-to-peer management approach guarantees high patient recruitment and retention in any clinical trial

High Speed Execution

  • We offer the quickest start-up times in each country.
  • Efficient Clinical Site Selection and Contracting.
  • Benefit from our extensive network of clinical sites and streamlined contracting process.

Operational Excellence

  • Proven record of delivering rescue studies, we consistently exceed industry performance standards.
  • Our team provides efficient query resolution to keep your trial on track.

Business Insight and Flexibility

  • We offer innovative pricing models and short lines of communication to ensure maximum flexibility and cost-effectiveness.
  • At Cohortias, we prioritize  short lines of communication to ensure efficient collaboration.
  • Swift adaptation to changes in the trial landscape to keep your study on schedule.

Rise of Clinical Trials in Colombia

We provide our services with offices in:

Colombia &

Daniela Maresca
Daniela Maresca | Country Lead Argentina
Martín Hernández-Torre | CMO
Maritza Rojas | CRA II
Pedro Alvarez | Business Development Manager
Samantha Rodriguez Cohortias
Samantha Rdz. | Start-Up Manager
Rise of Clinical Trials in Colombia

The Cohortias Team

Rise of Clinical Trials in Colombia

As the largest South American Contract research Organization, we know the Advantages and Challenges Of the Region

Let Us Guide You Through The Latin American Clinical Research Landscape

Rise of Clinical Trials in Colombia

Network & Partnerships